A programmable prompting device improves adherence to highly active antiretroviral therapy in HIV-infected subjects with memory impairment.

PubWeight™: 2.25‹?› | Rank: Top 2%

🔗 View Article (PMID 16107989)

Published in Clin Infect Dis on August 05, 2005

Authors

Adriana S A Andrade1, Henraya F McGruder, Albert W Wu, Shivaun A Celano, Richard L Skolasky, Ola A Selnes, I-Chan Huang, Justin C McArthur

Author Affiliations

1: Division of Infectious Diseases, Department of Medicine, The Johns Hopkins University, School of Medicine, Baltimore, Maryland 21205, USA. aandrade@jhmi.edu

Associated clinical trials:

A Multilevel Gaming Intervention for Persons on PrEP | NCT02611362

Articles citing this

Mobile phone technologies improve adherence to antiretroviral treatment in a resource-limited setting: a randomized controlled trial of text message reminders. AIDS (2011) 9.20

Efficacy of interventions in improving highly active antiretroviral therapy adherence and HIV-1 RNA viral load. A meta-analytic review of randomized controlled trials. J Acquir Immune Defic Syndr (2006) 4.49

Pillbox organizers are associated with improved adherence to HIV antiretroviral therapy and viral suppression: a marginal structural model analysis. Clin Infect Dis (2007) 3.16

Strategies for promoting adherence to antiretroviral therapy: a review of the literature. Curr Infect Dis Rep (2008) 2.30

The effectiveness of interventions using electronic reminders to improve adherence to chronic medication: a systematic review of the literature. J Am Med Inform Assoc (2012) 2.28

Randomized controlled trial of a personalized cellular phone reminder system to enhance adherence to antiretroviral therapy. AIDS Patient Care STDS (2011) 2.11

HIV-associated prospective memory impairment increases risk of dependence in everyday functioning. Neuropsychology (2008) 1.99

Timing is everything: antiretroviral nonadherence is associated with impairment in time-based prospective memory. J Int Neuropsychol Soc (2009) 1.94

Cell phone usage among adolescents in Uganda: acceptability for relaying health information. Health Educ Res (2011) 1.65

Prospective memory in HIV infection: is "remembering to remember" a unique predictor of self-reported medication management? Arch Clin Neuropsychol (2008) 1.59

Identification and assessment of adherence-enhancing interventions in studies assessing medication adherence through electronically compiled drug dosing histories: a systematic literature review and meta-analysis. Drugs (2013) 1.55

Markers of macrophage activation and axonal injury are associated with prospective memory in HIV-1 disease. Cogn Behav Neurol (2006) 1.47

Technology-based self-care methods of improving antiretroviral adherence: a systematic review. PLoS One (2011) 1.30

The role of prospective memory in medication adherence: a review of an emerging literature. J Behav Med (2011) 1.21

Methamphetamine use and neuropsychiatric factors are associated with antiretroviral non-adherence. AIDS Care (2012) 1.21

Two-way text messaging for health behavior change among human immunodeficiency virus-positive individuals. Telemed J E Health (2010) 1.20

The effect of reminder systems on patients' adherence to treatment. Patient Prefer Adherence (2012) 1.19

Text messaging-based smoking cessation intervention: a narrative review. Addict Behav (2013) 1.17

Relationship of prospective memory to neuropsychological function and antiretroviral adherence. Arch Clin Neuropsychol (2009) 1.15

A systematic review comparing antiretroviral adherence descriptive and intervention studies conducted in the USA. AIDS Care (2009) 1.14

Family experiences with pediatric antiretroviral therapy: responsibilities, barriers, and strategies for remembering medications. AIDS Patient Care STDS (2008) 1.07

A preliminary RCT of CBT-AD for adherence and depression among HIV-positive Latinos on the U.S.-Mexico border: the Nuevo Día study. AIDS Behav (2013) 1.01

Rodent models for HIV-associated neurocognitive disorders. Trends Neurosci (2012) 1.00

Effects of a Phone Call Intervention to Promote Adherence to Antiretroviral Therapy and Quality of Life of HIV/AIDS Patients in Baoshan, China: A Randomized Controlled Trial. AIDS Res Treat (2013) 0.99

Maximizing the impact of HIV prevention efforts: interventions for couples. AIDS Care (2013) 0.99

Relationships among neurocognitive status, medication adherence measured by pharmacy refill records, and virologic suppression in HIV-infected persons. J Acquir Immune Defic Syndr (2013) 0.95

Cognitive neurorehabilitation of HIV-associated neurocognitive disorders: a qualitative review and call to action. Neuropsychol Rev (2013) 0.95

Interventions for Enhancing Adherence to Antiretroviral Therapy (ART): A Systematic Review of High Quality Studies. AIDS Patient Care STDS (2015) 0.94

Identification of evidence-based interventions for promoting HIV medication adherence: findings from a systematic review of U.S.-based studies, 1996-2011. AIDS Behav (2014) 0.93

Prospective memory and antiretroviral medication non-adherence in HIV: an analysis of ongoing task delay length using the memory for intentions screening test. J Int Neuropsychol Soc (2012) 0.92

A comprehensive review of adherence to diabetes and cardiovascular medications in Iran; implications for practice and research. J Diabetes Metab Disord (2013) 0.92

Using a Mobile Health Intervention to Support HIV Treatment Adherence and Retention Among Patients at Risk for Disengaging with Care. AIDS Patient Care STDS (2016) 0.87

The Impact of Information Technology on Patient Engagement and Health Behavior Change: A Systematic Review of the Literature. JMIR Med Inform (2016) 0.86

Memory-based strategies for antiretroviral medication management: an evaluation of clinical predictors, adherence behavior awareness, and effectiveness. AIDS Behav (2013) 0.85

Barriers to antiretroviral therapy adherence and plasma HIV RNA suppression among AIDS clinical trials group study participants. AIDS Patient Care STDS (2015) 0.84

Strategies to improve HIV treatment adherence in developed countries: clinical management at the individual level. HIV AIDS (Auckl) (2011) 0.82

HIV-infected persons with bipolar disorder are less aware of memory deficits than HIV-infected persons without bipolar disorder. J Clin Exp Neuropsychol (2012) 0.81

The effect of medical device dose-memory functions on patients' adherence to treatment, confidence, and disease self-management. Patient Prefer Adherence (2014) 0.80

A novel computerized functional assessment for human immunodeficiency virus-associated neurocognitive disorder. J Neurovirol (2013) 0.80

Correlation between use of antiretroviral adherence devices by HIV-infected youth and plasma HIV RNA and self-reported adherence. AIDS Behav (2015) 0.78

A Comparison between The Effectiveness of Short Message Service and Reminder Cards Regarding Medication Adherence in Patients with Hypertension: A Randomized Controlled Clinical Trial. Int J Community Based Nurs Midwifery (2016) 0.78

A systematic review of medication non-adherence in persons with dementia or cognitive impairment. PLoS One (2017) 0.77

Cost-Effectiveness of Improving Health Care to People with HIV in Nicaragua. Nurs Res Pract (2014) 0.77

Cultural relevance in medication adherence interventions with underrepresented adults: systematic review and meta-analysis of outcomes. Prev Med (2014) 0.77

Differential focal and nonfocal prospective memory accuracy in a demographically diverse group of nondemented community-dwelling older adults. J Int Neuropsychol Soc (2014) 0.76

Drug Resistance and Virological Failure among HIV-Infected Patients after a Decade of Antiretroviral Treatment Expansion in Eight Provinces of China. PLoS One (2016) 0.75

Interventions to increase medication adherence in African-American and Latino populations: a literature review. Hawaii J Med Public Health (2014) 0.75

Psychosocial Correlates of Medication Adherence among HIV-Positive, Cognitively Impaired Individuals. J HIV AIDS Soc Serv (2016) 0.75

Articles by these authors

Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA (2005) 20.53

HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol (2010) 7.56

Methods to explain the clinical significance of health status measures. Mayo Clin Proc (2002) 7.00

Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system. Arch Neurol (2008) 6.91

The prevalence and incidence of neurocognitive impairment in the HAART era. AIDS (2007) 5.18

Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure. J Am Coll Cardiol (2003) 4.57

The International HIV Dementia Scale: a new rapid screening test for HIV dementia. AIDS (2005) 4.48

HIV-associated cognitive impairment before and after the advent of combination therapy. J Neurovirol (2002) 4.20

Incidents relating to the intra-hospital transfer of critically ill patients. An analysis of the reports submitted to the Australian Incident Monitoring Study in Intensive Care. Intensive Care Med (2004) 3.81

Correlates and predictors of adherence to highly active antiretroviral therapy: overview of published literature. J Acquir Immune Defic Syndr (2002) 3.55

In the wake of the 2003 and 2011 duty hours regulations, how do internal medicine interns spend their time? J Gen Intern Med (2013) 3.03

Stroke and encephalopathy after cardiac surgery: an update. Stroke (2005) 2.91

Continued high prevalence and adverse clinical impact of human immunodeficiency virus-associated sensory neuropathy in the era of combination antiretroviral therapy: the CHARTER Study. Arch Neurol (2010) 2.91

The relationship between a dementia diagnosis, chronic illness, medicare expenditures, and hospital use. J Am Geriatr Soc (2004) 2.89

Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance. AIDS (2009) 2.88

Depression is a risk factor for suboptimal adherence to highly active antiretroviral therapy. J Acquir Immune Defic Syndr (2002) 2.45

Atypical manifestations and poor outcome of herpes simplex encephalitis in the immunocompromised. Neurology (2012) 2.30

Prevalence of human immunodeficiency virus-associated cognitive impairment in a group of Hispanic women at risk for neurological impairment. J Neurovirol (2006) 2.27

Impact of nonoperative treatment, vertebroplasty, and kyphoplasty on survival and morbidity after vertebral compression fracture in the medicare population. J Bone Joint Surg Am (2013) 2.24

Evaluation of two methods for quality improvement in intensive care: facilitated incident monitoring and retrospective medical chart review. Crit Care Med (2003) 2.17

Extensive astrocyte infection is prominent in human immunodeficiency virus-associated dementia. Ann Neurol (2009) 2.14

Reducing health care hazards: lessons from the commercial aviation safety team. Health Aff (Millwood) (2009) 2.11

Changes in patient satisfaction related to hospital renovation: experience with a new clinical building. J Hosp Med (2015) 2.06

Chronic medical illness, depression, and use of acute medical services among Medicare beneficiaries. Med Care (2004) 2.00

Watershed strokes after cardiac surgery: diagnosis, etiology, and outcome. Stroke (2006) 1.98

Depressive symptoms, neurocognitive impairment, and adherence to highly active antiretroviral therapy among HIV-infected persons. Psychosomatics (2004) 1.98

Relationship between HAART adherence and adipose tissue alterations. J Acquir Immune Defic Syndr (2002) 1.97

ISOQOL recommends minimum standards for patient-reported outcome measures used in patient-centered outcomes and comparative effectiveness research. Qual Life Res (2013) 1.96

An evaluation of neurocognitive status and markers of immune activation as predictors of time to death in advanced HIV infection. Arch Neurol (2007) 1.94

Application of a propensity score approach for risk adjustment in profiling multiple physician groups on asthma care. Health Serv Res (2005) 1.92

The time course of epidermal nerve fibre regeneration: studies in normal controls and in people with diabetes, with and without neuropathy. Brain (2004) 1.90

Evaluating health outcomes in the presence of competing risks: a review of statistical methods and clinical applications. Med Care (2010) 1.88

Perturbation of sphingolipid metabolism and ceramide production in HIV-dementia. Ann Neurol (2004) 1.87

The use of patient-reported outcomes (PRO) within comparative effectiveness research: implications for clinical practice and health care policy. Med Care (2012) 1.84

Dendritic spine injury induced by the 8-hydroxy metabolite of efavirenz. J Pharmacol Exp Ther (2012) 1.79

Attenuated central nervous system infection in advanced HIV/AIDS with combination antiretroviral therapy. Arch Neurol (2004) 1.79

Asthma in older patients: factors associated with hospitalization. Arch Intern Med (2002) 1.77

The impact of anemia on energy and physical functioning in individuals with AIDS. Arch Intern Med (2005) 1.75

Depression symptoms and cognitive function among individuals with advanced HIV infection initiating HAART in Uganda. BMC Psychiatry (2010) 1.73

Off-pump surgery is associated with reduced occurrence of stroke and other morbidity as compared with traditional coronary artery bypass grafting: a meta-analysis of systematically reviewed trials. Stroke (2006) 1.73

Psychosocial risk factors of HIV morbidity and mortality: findings from the Multicenter AIDS Cohort Study (MACS). J Clin Exp Neuropsychol (2003) 1.70

Severity of HIV-associated neuropathy is associated with plasma HIV-1 RNA levels. AIDS (2002) 1.68

Do the SF-36 and WHOQOL-BREF measure the same constructs? Evidence from the Taiwan population*. Qual Life Res (2006) 1.67

HIV-associated sensory neuropathies. AIDS (2002) 1.65

PatientViewpoint: a website for patient-reported outcomes assessment. Qual Life Res (2009) 1.64

HIV subtype D is associated with dementia, compared with subtype A, in immunosuppressed individuals at risk of cognitive impairment in Kampala, Uganda. Clin Infect Dis (2009) 1.64

Evaluating sleep and cognition in HIV. J Acquir Immune Defic Syndr (2013) 1.64

Delirium after coronary artery bypass graft surgery and late mortality. Ann Neurol (2010) 1.63

Optimizing measurement of self-reported adherence with the ACTG Adherence Questionnaire: a cross-protocol analysis. J Acquir Immune Defic Syndr (2007) 1.62

A lipid storage-like disorder contributes to cognitive decline in HIV-infected subjects. Neurology (2013) 1.62

The effects of hospital and surgeon volume on postoperative complications after LumbarSpine surgery. Spine (Phila Pa 1976) (2011) 1.61

Gender differences in health-related quality of life in patients with HIV/AIDS. Qual Life Res (2005) 1.60

Measuring the transition readiness of youth with special healthcare needs: validation of the TRAQ--Transition Readiness Assessment Questionnaire. J Pediatr Psychol (2009) 1.59

Health care workers as second victims of medical errors. Pol Arch Med Wewn (2011) 1.58

Dysphagia after anterior cervical decompression and fusion: prevalence and risk factors from a longitudinal cohort study. Spine (Phila Pa 1976) (2005) 1.58

Clinical factors related to brain structure in HIV: the CHARTER study. J Neurovirol (2011) 1.57

Clinical validation of the NeuroScreen. J Neurovirol (2005) 1.57

HIV-associated neurocognitive disorders: is there a hidden epidemic? AIDS (2010) 1.56

A system factors analysis of airway events from the Intensive Care Unit Safety Reporting System (ICUSRS). Crit Care Med (2004) 1.56

Assessing HIV-associated dementia: modified HIV dementia scale versus the Grooved Pegboard. AIDS Read (2002) 1.56

Peripheral neuropathy in HIV: prevalence and risk factors. AIDS (2011) 1.53

Impact of indinavir on the quality of life in patients with advanced HIV infection treated with zidovudine and lamivudine. Clin Infect Dis (2004) 1.52

Critical pathway effectiveness: assessing the impact of patient, hospital care, and pathway characteristics using qualitative comparative analysis. Health Serv Res (2005) 1.51

Human immunodeficiency virus type 1 Nef protein mediates neural cell death: a neurotoxic role for IP-10. Virology (2004) 1.49

Neuropsychological test profile differences between young and old human immunodeficiency virus-positive individuals. J Neurovirol (2007) 1.49

Impact of bariatric surgery on health care utilization and costs among patients with diabetes. Med Care (2012) 1.49

A system factors analysis of "line, tube, and drain" incidents in the intensive care unit. Crit Care Med (2005) 1.48

Older patients with diverticulitis have low recurrence rates and rarely need surgery. Surgery (2011) 1.48

Parent perspectives of health related quality of life for adolescents with bladder exstrophy-epispadias as measured by the child health questionnaire-parent form 50. J Urol (2010) 1.47

Reproducibility of tDCS Results in a Randomized Trial: Failure to Replicate Findings of tDCS-Induced Enhancement of Verbal Fluency. Cogn Behav Neurol (2016) 1.47

Preventable hospitalization among elderly Medicare beneficiaries with type 2 diabetes. Diabetes Care (2003) 1.46

Length of red cell unit storage and risk for delirium after cardiac surgery. Anesth Analg (2014) 1.46

Diagnostic utility of the subjective peripheral neuropathy screen in HIV-infected persons with peripheral sensory polyneuropathy. AIDS Read (2005) 1.46

Intraoperative hemoglobin levels and transfusion independently predict stroke after cardiac operations. Ann Thorac Surg (2011) 1.45

Low atazanavir concentrations in cerebrospinal fluid. AIDS (2009) 1.45

Abeta deposition is associated with enhanced cortical alpha-synuclein lesions in Lewy body diseases. Neurobiol Aging (2004) 1.44

Normative data for determining significance of test-retest differences on eight common neuropsychological instruments. Clin Neuropsychol (2004) 1.44

Subjective memory symptoms in surgical and nonsurgical coronary artery patients: 6-year follow-up. Ann Thorac Surg (2009) 1.43

Quantitative MR spectroscopic imaging of brain lesions in patients with AIDS: correlation with [11C-methyl]thymidine PET and thallium-201 SPECT. Acad Radiol (2002) 1.43

Risk and promotive factors in families, schools, and communities: a contextual model of positive youth development in adolescence. Pediatrics (2007) 1.43

Health care professionals as second victims after adverse events: a systematic review. Eval Health Prof (2012) 1.42

Characterization of the follicular dendritic cell reservoir of human immunodeficiency virus type 1. J Virol (2008) 1.40

Toward learning from patient safety reporting systems. J Crit Care (2006) 1.40

Quality of life in tuberculosis: patient and provider perspectives. Qual Life Res (2004) 1.39

Acute decompensation after removing a central line: practical approaches to increasing safety in the intensive care unit. Ann Intern Med (2004) 1.39

The timing of surgical staging has a significant impact on the complications and functional outcomes of adult spinal deformity surgery. Spine J (2013) 1.39

Schwann cell chemokine receptors mediate HIV-1 gp120 toxicity to sensory neurons. Ann Neurol (2003) 1.39

An end to the witch hunts: responding to the defenders of blame and shame. A commentary on Collins, Block, Arnold and Christakis. Soc Sci Med (2009) 1.39

Evaluation of a clinical screening tool for HIV-associated sensory neuropathies. Neurology (2005) 1.39

Partnership with patients: a prescription for ICU safety. Chest (2006) 1.38